scholarly journals A simple strategy for retargeting lentiviral vectors to desired cell types via a disulfide-bond-forming protein-peptide pair

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Nagarjun Kasaraneni ◽  
Ana M. Chamoun-Emanuelli ◽  
Gus A. Wright ◽  
Zhilei Chen
1988 ◽  
Vol 36 (9) ◽  
pp. 3304-3311 ◽  
Author(s):  
NOBUTAKA FUJII ◽  
TOSHIHIRO WATANABE ◽  
TAMAKI AOTAKE ◽  
AKIRA OTAKA ◽  
ITSUO YAMAMOTO ◽  
...  

2007 ◽  
Vol 282 (14) ◽  
pp. 10263-10271 ◽  
Author(s):  
Timothy L. Tapley ◽  
Timo Eichner ◽  
Stefan Gleiter ◽  
David P. Ballou ◽  
James C. A. Bardwell

2015 ◽  
Vol 198 (5) ◽  
pp. 746-754 ◽  
Author(s):  
Melissa E. Reardon-Robinson ◽  
Hung Ton-That

Disulfide bonds are important for the stability and function of many secreted proteins. In Gram-negative bacteria, these linkages are catalyzed by thiol-disulfide oxidoreductases (Dsb) in the periplasm. Protein oxidation has been well studied in these organisms, but it has not fully been explored in Gram-positive bacteria, which lack traditional periplasmic compartments. Recent bioinformatics analyses have suggested that the high-GC-content bacteria (i.e., actinobacteria) rely on disulfide-bond-forming pathways. In support of this, Dsb-like proteins have been identified inMycobacterium tuberculosis, but their functions are not known.Actinomyces orisandCorynebacterium diphtheriaehave recently emerged as models to study disulfide bond formation in actinobacteria. In both organisms, disulfide bonds are catalyzed by the membrane-bound oxidoreductase MdbA. Remarkably, unlike known Dsb proteins, MdbA is important for pathogenesis and growth, which makes it a potential target for new antibacterial drugs. This review will discuss disulfide-bond-forming pathways in bacteria, with a special focus on Gram-positive bacteria.


Viruses ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 1103 ◽  
Author(s):  
Luis Apolonia

Lentiviral vectors have been developed and used in multiple gene and cell therapy applications. One of their main advantages over other vectors is the ability to integrate the genetic material into the genome of the host. However, this can also be a disadvantage as it may lead to insertional mutagenesis. To address this, non-integrating lentiviral vectors (NILVs) were developed. To generate NILVs, it is possible to introduce mutations in the viral enzyme integrase and/or mutations on the viral DNA recognised by integrase (the attachment sites). NILVs are able to stably express transgenes from episomal DNA in non-dividing cells or transiently if the target cells divide. It has been shown that these vectors are able to transduce multiple cell types and tissues. These characteristics make NILVs ideal vectors to use in vaccination and immunotherapies, among other applications. They also open future prospects for NILVs as tools for the delivery of CRISPR/Cas9 components, a recent revolutionary technology now widely used for gene editing and repair.


2010 ◽  
Vol 399 (2) ◽  
pp. 268-282 ◽  
Author(s):  
Lindsay J. Sperling ◽  
Deborah A. Berthold ◽  
Terry L. Sasser ◽  
Victoria Jeisy-Scott ◽  
Chad M. Rienstra

Sign in / Sign up

Export Citation Format

Share Document